Skip to main content
OpenTrials

Clinical trial condition

Refractory Generalized Myasthenia Gravis

Explore clinical trials studying Refractory Generalized Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Refractory Generalized Myasthenia Gravis trial results

Completed

Extension Study of ECU-MG-301 to Evaluate Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis

NCT02301624

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Birmingham, Alabama, United States
  • Los Angeles, California, United States
  • Orange, California, United States
  • Palo Alto, California, United States
View all 60 locations
View Trial Details

Related conditions